Ecovyst Inc. splits its revenue into 3 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Regeneration And Treatment Services at $361.2 million, 50% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
869
|
724
|
598
|
585
|
820
|
611
|
496
|
533
|
1,229
|
—
|
| Regeneration And Treatment Services |
—
|
361
+1.1%
share 49.9%
|
357
+0.8%
share 59.7%
|
355
share 60.6%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Industrial Mining Automotive |
—
|
328
+58.5%
share 45.3%
|
207
+3.3%
share 34.6%
|
200
share 34.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Other Services |
—
|
34
+1.0%
share 4.7%
|
34
+13.9%
share 5.7%
|
30
share 5.1%
|
—
|
—
|
—
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- ECVT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1708035
- Former names
- PQ Group Holdings Inc. (until Jul 23, 2021)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Innospec Inc. IOSP
- Chemours Co CC
- OLIN Corp OLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.